<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        95-6-01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DAKTARIN 2% TINCTURE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MICONAZOLE NITRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LUSOMEDICAMENTA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LUSOMEDICAMENTA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            JANSSEN-CILAG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D01AC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DAKTARIN Tincture is a medicine for treating <strong>infection of the nail by fungi including yeasts</strong>. Sometimes, it constitutes only part of the treatment and other medicines have to be taken as well.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use DAKTARIN Tincture if you know you are <strong>hypersensitive</strong> to it or to other similar antifungal medicines.</p><p><strong>Do not bring DAKTARIN Tincture</strong> <strong>into contact with open wounds, the eyes, or mucous membranes</strong>.</p><p>Keep a towel and a washcloth for your own use. In this way you <strong>avoid infecting other</strong> <strong>people</strong>. Regularly change clothing which comes into contact with the infected skin in order to avoid reinfecting yourself.</p><p>Oral anticoagulants (blood thinning medication): Ask a doctor or pharmacist before use if you are taking an oral blood thinning medication, such as warfarin.</p><p><strong><em>&nbsp;</em></strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;<strong>Pregnancy and breast-feeding</strong></p><p>DAKTARIN Tincture is minimally absorbed into the body when applied on the nail/skin. It is not known whether the active ingredient is excreted in human breast milk. If you are pregnant or nursing a baby, ask your doctor if you should use DAKTARIN Tincture.<strong><em> </em></strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>For a successful treatment, <strong>apply DAKTARIN Tincture every day</strong>.<strong> </strong></p><p><strong>DAKTARIN Tincture</strong> <strong>is applied with a brush which is attached to the cap of the bottle</strong>.</p><p>Cut the infected nail as short as possible. <strong>Once to twice a day</strong>, apply some tincture to the nail, the area around it and, if possible, under it. Allow to dry. After the tincture has dried, an occlusive film remains.</p><p><strong>Before applying the tincture again</strong>, you should <strong>clean</strong> the nail with a swab saturated with acetone (sometimes also used to remove nail polish). If this is not done, the layers will become too thick and the medicine in DAKTARIN cannot reach the nail any more.</p><p>You should continue the treatment until a new nail starts growing. Stop using DAKTARIN Tincture only after you have seen that this nail is completely normal. That will take at least 3 months.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DAKTARIN Tincture is usually well tolerated.</p><p>In rare cases, redness, irritation,and/or a mildly burning or itching sensation may occur at the site where you have applied DAKTARIN Tincture. In such cases, it is usually sufficient to skip one or a few applications.</p><p>Hypersensitivity to DAKTARIN is very rare. It can be recognized by itching, redness, shortness of breath, and/or a swollen face following an application. In this case you should stop the treatment and consult your doctor or pharmacist.</p><p>Do not hesitate to report any other undesired effects to your doctor or pharmacist.</p><p>When DAKTARIN Tincture is applied more frequently than prescribed, it may cause some redness, swelling or a burning sensation. In this case, it is sufficient to skip one or two applications and start again according to the normal scheme.</p><p>Accidental swallowing of DAKTARIN Tincture may cause stomach irritation. Call your doctor to make sure that there are no problems.</p><p><strong>&nbsp;</strong></p><p>Information for the doctor in case of overdose</p><p><em>A specific antidote is not available. Treatment is symptomatic and supportive. However, the quantity of alcohol that has been ingested must be taken into account, especially in children. If the patient is also taking certain other medicines (e.g., warfarin, oral hypoglycemics, and phenytoin), their effects and side effects may be strengthened. </em></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always keep the bottle properly closed. This medicine can be kept for only a limited period. Do not use DAKTARIN Tincture after the date (month and year) printed after &quot;EXP&quot;, even if it has been stored properly.</p><p>You are advised to return old medicines to your pharmacist.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DAKTARIN Tincture is a medicine for treating infection of the nail by fungi including yeasts. The active ingredient in DAKTARIN Tincture is <strong>miconazole</strong>.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                DAKTARIN Tincture comes in bottles of 30 millilitres with a brush attached to the cap and contains 20 milligrams miconazole per millilitre. 
The tincture also contains other ingredients, namely: acrylic/acrylate copolymers, alcohol, and propylene glycol. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Registration holder/Manufacturer:</p><p>To be completed by the operating company.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02 January 2014 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">تستخدم صبغة دكتارين لعلاج <strong>عدوى الأظافر بالفطريات بما فيها الخمائر.</strong></p><p dir="RTL">أحيانًاً ، تكون هذه الصبغة جزءًاً فقط من العلاج، ويلزم استخدام أدوية أخرى معها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تستخدم صبغة دكتارين إذا كنت تعلم أنك مصاب <strong>بفرط الحساسية تجاهها</strong> أو تجاه مضادات فطريات مشابهة أخرى.</p><p dir="RTL"><strong>ما الاحتياطات الخاصة التي ينبغي اتخاذها؟</strong></p><p dir="RTL"><strong>احترس من ملامسة صبغة دكتارين للجروح المفتوحة أو العينين أو الأغشية المخاطية</strong>.</p><p dir="RTL">احتفظ بمنشفة وفوطة خاصة بك وحدك. بهذه الطريقة <strong>تتجنب انتقال العدوى إلى الآخرين</strong>. احرص على استبدال الملابس الملامسة للجلد المصاب بانتظام لتجنب تكارر العدوى لنفسك.</p><p dir="RTL">مضادات التخثر (مرققات الدم) الفموية: يجب استشاةر الطبيب أو الصيدلي قبل استخدام أي دواء مرقق للدم يؤخذ عن طريق الفم مثل وارفارين.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--><!--[if gte vml 1]><v:group id="Group_x0020_12911" o:spid="_x0000_s1026"
 style='width:58.5pt;height:32.15pt;mso-position-horizontal-relative:char;
 mso-position-vertical-relative:line' coordsize="7427,4081" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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=
">
 <v:rect id="Rectangle_x0020_289" o:spid="_x0000_s1027" style='position:absolute;
  left:3535;top:1548;width:643;height:3369;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal align=left style='text-align:left;direction:ltr;
     unicode-bidi:embed'><b style='mso-bidi-font-weight:normal'><span
     style='font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:107%'><span
     style='mso-spacerun:yes'> </span></span></b><o:p></o:p></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:shape id="Shape_x0020_465" o:spid="_x0000_s1028" style='position:absolute;
  left:4093;top:219;width:835;height:2971;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="83516,297114" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m83516,r,5914l83046,6200r470,2857l83516,57700,82107,47691,80697,37676,79288,28138,78818,18123,78349,9061r,477l69893,15261r-7515,6200l54863,28138r-7047,7154l40770,42922r-6107,8107l29026,59137r-5167,9061l19162,77260r-4228,9538l11646,96336,8827,106351,6479,116842,4600,127335r-940,10492l3191,148796r,8108l4130,165011r939,7630l6009,180749r1879,7630l9767,195533r2349,7631l14934,210317r2818,7153l21041,224148r3757,6676l28556,237501r4228,6200l37012,249900r4697,5723l46876,261346r1409,-5246l48755,250377r940,-6199l50634,236547r2349,-8584l56741,217947r5637,-11445l70363,193148r6107,-8584l82576,177887r940,-1040l83516,185306r-940,1166l78349,191718r-4227,6199l69893,204594r-4227,6677l61908,219378r-3288,8107l55801,236070r-1879,9538l52513,255623r-470,10969l58620,272793r7046,6199l73182,284714r7985,4770l83516,290886r,6228l71772,289961,59089,279946,47346,268977,36542,257054,26678,244178,18222,229870,11176,215087,5539,199348,1312,183133,,173544,,124048r1312,-9590l5539,98244,11176,82505,18222,67721,26678,53414,36542,40538,47346,28138,59089,17169,71772,7154,83516,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,83516,297114"/>
 </v:shape><v:shape id="Shape_x0020_466" o:spid="_x0000_s1029" style='position:absolute;
  left:4928;width:1795;height:3370;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="179441,337094" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m82204,l99115,954r16910,2385l131997,7631r15501,5723l162061,20507r14091,8585l179441,31689r,6703l176622,36246r-9395,-6677l156893,23847,146398,18750r-309,-627l146089,18600r309,150l147028,20031r1879,4769l151726,29092r2348,4293l156893,37676r2818,3815l161590,45307r1409,3815l163469,52461r-939,4291l160651,61999r-3289,5246l154074,72491r-4227,4769l146559,82029r-3288,3338l141391,87752r3289,3815l148907,98244r5167,8107l159241,115412r4698,8585l168166,131628r2819,5723l172394,140212r7047,30151l179441,194106r-1,-4l178031,192194r-1879,-2861l174743,183611r-1409,-6678l172394,171210r-469,-5245l170985,161196r-470,-3816l169576,153088r-940,-3815l167697,144981r-1879,-4292l163939,135920r-2349,-5723l158302,124474r-4228,-7154l149377,109689r-5637,-9060l137164,90136r-2349,955l132466,92521r-2348,1431l127769,95383r-1879,1430l124481,97767r-1409,953l122602,99198r-3758,l119783,97767r,-477l119314,97290r-470,-954l120723,94428r4228,-3337l131527,86321r7046,-5723l145619,73922r6577,-7154l156423,59614r1879,-7153l157832,50076r-1409,-2862l154544,43400r-2348,-3339l149377,36246r-1879,-2861l145619,31000r-939,-1431l142801,25277r-1410,-3339l140452,18600r-470,-2861l135285,13831r-4698,-1431l125420,10969,120723,9539r-5167,-954l110858,7631r-5167,-954l100524,6200r-470,1908l99585,9539r-940,l98645,14785r470,2861l99115,33385r-470,8584l98175,43400r-939,953l96766,44831r-470,l96296,49122r470,2385l96766,67721r-470,9539l95827,78691r-940,953l94417,80121r-469,l93948,82983r469,1907l94417,91567r470,5246l94417,103013r-469,8585l93478,113028r-470,953l92069,114459r-470,l91599,149751r1409,5245l94417,160242r1410,4292l97236,168827r1409,4769l99585,177888r469,5246l100524,188380r,11445l100054,204594r-469,7154l98175,220809r-1409,10492l95358,241316r-941,9062l93008,257055r-469,4292l92539,263254r469,1431l93008,270408r470,4770l93008,281377r-469,8107l92069,295684r-470,5246l91129,306176r-939,5246l89720,316668r-470,4769l88311,327160r-470,6200l87841,335745r5167,l95827,335267r2818,l100994,334791r2818,-477l106161,334314r2818,-477l108979,291869r1410,-2862l114147,286146r5167,-3338l126360,278992r7047,-4292l141391,269454r7046,-6200l155014,255147r5167,-8585l164878,237502r4228,-10016l172394,217949r3288,-8108l178031,202687r1409,-4292l179441,198392r,17766l178501,218425r-4228,10492l169576,238932r-4228,9061l161590,256101r-2818,5246l155953,264208r-4697,4292l144680,273269r-7047,4769l130587,282808r-7045,4292l117904,290438r-3757,1431l114617,300930r469,7154l115086,332407r13622,-3339l141861,324299r12683,-5723l166757,311899r11274,-7630l179441,303149r,6153l176152,311899r-14091,8585l147498,327637r-15501,5723l118101,337094r-71793,l32412,333360,16911,327637,2349,320484,,319053r,-6229l5637,316191r8455,4293l22547,324299r8925,3338l31472,324776r-469,-954l31003,322391r-470,-2385l30063,316668r-469,-4292l28655,306653r-940,-7631l26775,290438r,-5722l27245,282808r,-5723l26775,273269r-470,-1431l25836,270885r-940,-477l24426,270408r,-60567l23957,206980r-470,-3340l22547,199825r-939,-3815l20199,192672r-939,-3339l18320,186949r-470,-1908l15971,187903r-2349,3338l10804,194580r-3758,4292l3288,203164,,207244r,-8459l4228,194102r4697,-5245l12683,183611r2818,-7154l17380,167873r470,-11924l17380,153565r-469,-3338l15501,145458r-1409,-5723l12683,133058r-2349,-7631l8455,117320,6576,108259,4228,99198,2349,89660,1,79644r-1,-5l,30995r1,5l939,37199r940,8585l3288,56276,4697,67245,6107,77736r1409,9062l8455,93952r2819,13353l14092,118751r2349,9061l18790,135443r1879,6200l22078,146889r469,4292l23017,155473r,3338l22547,162150r-469,2861l22078,167873r-470,1907l21138,171688r-469,953l20669,173118r469,2862l22078,180273r1879,5722l25836,192194r1409,6201l29124,203164r939,3816l30533,208410r,26230l30063,240363r,11922l30533,259439r470,1430l31942,261824r470,476l32882,262777r,1431l32412,265162r,1431l31942,269454r,4292l32412,280423r470,9061l33351,295684r470,5723l34291,307130r939,5723l35700,318098r,10970l41337,330498r5637,1431l52611,332884r5637,953l63884,334791r6107,476l76098,335745r6576,l83144,329544r470,-7153l84553,315715r940,-7155l86432,301884r939,-5722l88311,291392r470,-3338l88781,287576r-470,-1430l88311,280900r-470,-3815l87841,272315r470,-5722l88781,259439r939,-8585l90660,243224r1409,-7153l93008,228917r940,-7154l94887,214609r471,-7629l95358,188857,86432,150704r,-13831l86902,135443r939,-954l88311,134489r470,-477l88781,131151r-470,-1908l88311,122566r-470,-5246l88311,111120r470,-8584l89250,100629r940,-954l90660,99198r469,l91129,96336r-469,-1908l90660,87752r-470,-5246l90660,76306r469,-8585l91599,66291r470,-954l92539,64860r469,l93008,60568r-469,-2385l92539,41969r469,-9538l93478,31000r939,-955l94887,29569r471,l95358,28138r-471,-1908l94887,11923r471,-6199l92069,5247r-15501,l70931,5724r-5637,476l60127,6677r-5637,954l49323,8585r-5168,1431l38988,10969r-5167,1908l28655,14308r-5168,1907l18320,18123r-4698,2384l8925,22892,4228,25277,,27852,,21938,2349,20507,16911,13354,32412,7631,48383,3339,65294,954,82204,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,179441,337094"/>
 </v:shape><v:shape id="Shape_x0020_467" o:spid="_x0000_s1030" style='position:absolute;
  left:6723;top:1703;width:61;height:458;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="6106,45795" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l6106,26124r-940,5245l2818,39001,,45795,,28029,469,26124,,23743,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,6106,45795"/>
 </v:shape><v:shape id="Shape_x0020_468" o:spid="_x0000_s1031" style='position:absolute;
  left:6723;top:316;width:704;height:2777;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="70461,277613" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m,l9394,7418,21138,18387,31942,30787r9865,12876l50262,57971r7045,14783l62944,88493r4228,16215l69521,121876r940,17169l69521,156215r-2349,17167l62944,189598r-5637,15738l50262,220120r-8455,14308l31942,247304,21138,259226,9394,270195,,277613r,-6153l9394,263996r9865,-9539l28184,243966r8455,-10969l43685,221073r6577,-12399l55428,195797r4229,-13353l62944,168136r1879,-14307l65293,139045r-470,-12877l63414,113769,61066,101847,58247,89924,54019,78478,49323,67509,44155,57017,38048,47002,31003,37464,23486,28402,15501,19818,6576,11711,,6703,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,70461,277613"/>
 </v:shape><v:shape id="Shape_x0020_477" o:spid="_x0000_s1032" style='position:absolute;
  top:249;width:838;height:2911;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="83808,291141" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m83808,r,5766l80401,8034r-9539,5447l62686,20292r-6815,6807l47696,33907r6814,l62686,32547,73588,29822,83808,28802r,5397l76313,35269,43608,39354,35432,51610,27256,62505,20442,74760,14991,88378r-4088,13618l8179,115612,5452,130591r,29958l9541,156464r4088,-5447l20442,144210r6814,-6811l36795,130591r5450,-2724l47696,126505r5451,-2723l59959,122422r6815,-1363l73588,121059r6813,l83808,121741r,6013l76313,126505r-10901,1362l58598,129229r-5451,1362l47696,131954r-5451,2722l32707,140125r-8177,6807l20442,151017r-4088,4085l13629,157827r-2726,4086l8179,165998r-1060,3176l6815,167358r,2725l7119,169174r1060,6354l9541,183699r4088,14979l20442,213657r2726,6809l27256,227275r2724,1361l31344,229999r2726,2722l36795,234084r2725,2722l64050,239530r19077,1362l83808,241005r,6128l79039,246338,65412,244977,46334,242253r-6814,-1361l34070,238170r5450,6807l46334,253147r5450,6811l59959,266765r6815,6810l74950,279020r8177,5447l83808,284921r,6220l74950,285831,61323,276297,49059,265403,38159,253147r-4089,-6809l28618,239530,20442,225914r-4088,-6810l13629,210934r-2726,-8171l8179,195955,4091,179614,2727,171443,1364,161913,,145570,1364,127867,4091,111527r1361,-8171l8179,95186,13629,78845,20442,65228,28618,50250,38159,37993,49059,25737,61323,14843,68137,9396,74950,5311,83808,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,83808,291141"/>
 </v:shape><v:shape id="Shape_x0020_478" o:spid="_x0000_s1033" style='position:absolute;
  left:838;top:3098;width:708;height:272;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="70861,27214" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l7495,4994r9538,4085l25210,13164r9539,4085l44288,19972r10901,1362l64728,22697r6133,874l70861,27214r-14567,l51101,26782,42925,24057,34749,22697,19759,15887,4769,9079,,6220,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,70861,27214"/>
 </v:shape><v:shape id="Shape_x0020_479" o:spid="_x0000_s1034" style='position:absolute;
  left:838;top:2256;width:708;height:621;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="70861,62143" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m70861,r,8170l66092,8850r-8179,2724l49738,15659r-9537,5448l36113,23829r-4091,2724l27934,30638r-2724,4085l22484,38808r-2725,4086l55189,52425r15672,4699l70861,62143r-681,-186l56552,57872,32022,52425,11583,48340,,46411,,40283r7495,1249l12945,42894,21122,32000r9539,-9532l38837,15659r8176,-4085l52464,7489,63366,3404,70180,680,70861,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,70861,62143"/>
 </v:shape><v:shape id="Shape_x0020_480" o:spid="_x0000_s1035" style='position:absolute;
  left:838;top:1466;width:708;height:705;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="70861,70469" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l3406,681r8177,1361l18396,4765r6814,4086l32022,14298r5452,4086l45650,27915r4088,6808l53827,41532r5450,10895l62001,53787r6815,4086l70861,60937r,9532l68816,67405,63366,60598,55189,53787,52464,51064,51101,48342,45650,38808,41562,32000,34749,23830,26572,17021,19759,12936,12945,8851,681,6127,,6014,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,70861,70469"/>
 </v:shape><v:shape id="Shape_x0020_481" o:spid="_x0000_s1036" style='position:absolute;
  left:838;top:16;width:708;height:575;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="70861,57483" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m67454,r3407,l70861,5700,62001,6807,49738,8168,38837,10892r1364,4085l40201,20424r1361,6809l41562,31318r-1361,2724l37474,38127r-1361,2723l33386,43576r-4088,2721l21122,50383r-9539,4085l2042,57191,,57483,,52086r3406,-340l15671,47661r5451,-2725l26572,42212r4089,-2722l33386,36765r2727,-4085l36113,20424,34749,16339,33386,13617r-9539,2722l14308,20424,4769,25873,,29049,,23284,4769,20424r6814,-4085l19759,12254,26572,9532,34749,6807,51101,2722,59277,1360,67454,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,70861,57483"/>
 </v:shape><v:shape id="Shape_x0020_482" o:spid="_x0000_s1037" style='position:absolute;
  left:1546;top:3102;width:1002;height:268;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="100157,26760" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQAEF5CXxAAAANwAAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9Ba8JA
FITvgv9heYXezG5EiqRZQyhWvBWtxR4f2WcSmn0bslsT/31XEHocZuYbJi8m24krDb51rCFNFAji
ypmWaw2nz/fFGoQPyAY7x6ThRh6KzXyWY2bcyAe6HkMtIoR9hhqaEPpMSl81ZNEnrieO3sUNFkOU
Qy3NgGOE204ulXqRFluOCw329NZQ9XP8tRoO50ql3+eP0Zf7cqf6rwtub1Lr56epfAURaAr/4Ud7
bzSs1ku4n4lHQG7+AAAA//8DAFBLAQItABQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAAAAAAAAA
AAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1sUEsBAi0AFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsA
AAAAAAAAAAAAAAAAHwEAAF9yZWxzLy5yZWxzUEsBAi0AFAAGAAgAAAAhAAQXkJfEAAAA3AAAAA8A
AAAAAAAAAAAAAAAABwIAAGRycy9kb3ducmV2LnhtbFBLBQYAAAAAAwADALcAAAD4AgAAAAA=
" path="m100157,r,5655l94707,8625r-6813,4084l79718,15432r-6815,4086l64728,22243,48376,26328r-2596,432l,26760,,23117r3406,486l29298,23603r8176,-1360l44288,20879,57915,18158,71541,14071,85170,8625,97433,1815,100157,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,100157,26760"/>
 </v:shape><v:shape id="Shape_x0020_483" o:spid="_x0000_s1038" style='position:absolute;
  left:1546;top:2827;width:1002;height:362;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="100157,36155" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m,l11583,3473r21803,6809l49738,15729r20441,8171l76991,26622r6815,2723l85170,26622r4087,-4085l97433,15729r2724,-2043l100157,20154r-1361,1021l94707,25260r-5450,4085l85170,36155,45650,21175,14308,8920,,5019,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,100157,36155"/>
 </v:shape><v:shape id="Shape_x0020_484" o:spid="_x0000_s1039" style='position:absolute;
  left:1546;top:2076;width:1002;height:609;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="100157,60937" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l681,1021,3406,3744,4769,6468r,2724l6132,14638r,5447l12945,21448r6814,1361l33386,26894r14990,5447l63365,39151,86532,50043r6813,4085l98796,55492r1361,-1363l100157,60257r-1361,680l93345,59575,83806,55492,57915,43236,42923,36426,27935,30979,14308,26894,8857,25533r-4088,l,26214,,18044r681,-681l681,10553,,9532,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,100157,60937"/>
 </v:shape><v:shape id="Shape_x0020_485" o:spid="_x0000_s1040" style='position:absolute;
  left:2289;top:2058;width:191;height:96;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="19078,9533" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l2724,,5451,4086,6815,5447,8176,6810,10903,5447,12264,4086,13627,2724,14990,r4088,l17715,4086,16352,6810,14990,8171r-1363,l9539,9533,5451,8171r-1363,l2724,6810,1363,4086,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,19078,9533"/>
 </v:shape><v:shape id="Shape_x0020_486" o:spid="_x0000_s1041" style='position:absolute;
  left:1826;top:1759;width:722;height:667;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="72222,66726" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l2725,r,10895l4088,16341r1363,8170l8176,34044r1363,4085l12264,42214r2724,4085l19076,50385r4091,2724l27255,57194r5450,2722l38155,61278r6813,1362l53147,62640r5449,1362l64047,62640r5451,l72222,61551r,3359l70860,65363r-6813,1363l53147,66726r-5452,l40881,65363,35430,64002,29980,62640,21803,57194,17715,53109,13627,50385,10902,46299,8176,42214,2725,32682,,21788,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,72222,66726"/>
 </v:shape><v:shape id="Shape_x0020_487" o:spid="_x0000_s1042" style='position:absolute;
  left:1546;top:16;width:1002;height:572;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="100157,57192" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l32023,,48376,2722r8176,2723l64728,6807r14990,5447l94707,20424r5450,2971l100157,28595,96070,25873,86532,20424,75630,16339,66091,12254r-1363,6808l63365,23148r,8170l66091,35403r2725,4087l74267,42212r4088,2724l85170,47661r12263,4085l100157,52350r,4842l93345,55831,79718,51746,72903,49021,67453,44936,63365,42212,60640,38127,57915,32680r,-12256l60640,10892,49738,8168,38837,6807,26572,5445,14308,4083,2044,5445,,5700,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,100157,57192"/>
 </v:shape><v:shape id="Shape_x0020_488" o:spid="_x0000_s1043" style='position:absolute;
  left:2548;top:1759;width:354;height:649;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="35431,64910" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQAlcUOwwgAAANwAAAAPAAAAZHJzL2Rvd25yZXYueG1sRE9Na8JA
EL0X/A/LCL2UurEkQWI2ImqLVzXQ65idJqHZ2ZBdTdpf7x4KPT7ed76ZTCfuNLjWsoLlIgJBXFnd
cq2gvLy/rkA4j6yxs0wKfsjBppg95ZhpO/KJ7mdfixDCLkMFjfd9JqWrGjLoFrYnDtyXHQz6AIda
6gHHEG46+RZFqTTYcmhosKddQ9X3+WYU3D70b8LXw4s/pbWL9/vks5SJUs/zabsG4Wny/+I/91Er
iFdhbTgTjoAsHgAAAP//AwBQSwECLQAUAAYACAAAACEA2+H2y+4AAACFAQAAEwAAAAAAAAAAAAAA
AAAAAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQBa9CxbvwAAABUBAAALAAAA
AAAAAAAAAAAAAB8BAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQAlcUOwwgAAANwAAAAPAAAA
AAAAAAAAAAAAAAcCAABkcnMvZG93bnJldi54bWxQSwUGAAAAAAMAAwC3AAAA9gIAAAAA
" path="m32705,r,1363l34068,1363r,1360l35431,4085,34068,6810r,16341l32705,28597r-1362,5447l28618,38129r-1363,4085l20441,50385r-6813,6809l6813,62640,,64910,,61551,4089,59916r6815,-4085l13628,53109r2725,-4085l23167,42214r4088,-9532l28618,27236r1362,-5448l31343,16341r,-14978l32705,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,35431,64910"/>
 </v:shape><v:shape id="Shape_x0020_489" o:spid="_x0000_s1044" style='position:absolute;
  left:2548;top:250;width:817;height:2909;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="81736,290919" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l9540,5200r12264,9532l34068,25626,44970,37881r5451,5447l54509,50138r8175,14978l66775,71926r2724,6807l73587,86904r2725,8170l80401,111415r1335,8007l81736,170828r-1335,8674l77675,187674r-1363,8170l69499,210822r-6815,14981l54509,239419r-9539,13617l34068,265292,21804,276185,9540,285719,,290919r,-5655l9540,278909r10901,-8170l12265,270739r-8176,4085l,277888r,-6468l2725,269377r4088,-2723l10904,265292r14988,l35431,255760r8176,-9533l51784,235333r6812,-10894l28618,232610r-17714,5448l1363,242142,,242823r,-6127l1,236695r5451,-1362l12265,231248r12265,-4085l38157,223078r10901,-2724l57234,218992r4089,-1360l65411,209460r4088,-8170l72224,191759r2726,-8172l76312,174056r1363,-9533l79038,145459,77675,130480,76312,115500r-1362,-6808l72224,101884,68136,88267,62684,76011,55872,63754,49058,51498,40884,40605,20441,37881,6813,35158,,33796,,28955r9540,2118l21804,32435r9539,1361l34068,35158r2725,l29980,28350,21804,21541,13628,14732,4089,7923,,5200,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,81736,290919"/>
 </v:shape><w:wrap type="none"/>
 <w:anchorlock/>
</v:group><![endif]--><img width="79" height="54" src="file:///C:/Users/falmajmo/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.gif" /><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:58.5pt;
 height:32.15pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]-->&nbsp;<strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">تُمتص صبغة دكتارين بدرجة ضئيلة داخل الجسم عند وضعها على الأظافر/الجلد. وليس معلومًا هل تفرز المادة الفعالة في حليب الأم أم لا. إذا كانت المريضة حاملاً أو مُرضعا؛ فينبغي أن تستشير الطبيب بشأن استخدام صبغة دكتارين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>طريقة استخدام صبغة دكتارين ومقدار الجرعة</strong> لنجاح العلاج، <strong>استخدم صبغة دكتارين كل يوم</strong>.</p><p dir="RTL"><strong>توضع صبغة دكتارين باستخدام الفرشاة المثبتة بغطاء الزجاجة.</strong></p><p dir="RTL">يُقص الظفر المصاب لأقصى درجة ممكنة .<strong>يدهن الظفر المصاب والمنطقة المحيطة به والمنطقة التي تحته - إن </strong></p><p dir="RTL"><strong>أمكن - بكمية من الصبغة مرة واحدة أو مرتين في اليوم</strong>. انتظر حتى تجف الصبغة. تبقى طبقة رقيقة مُسِدة بعد جفاف الصبغة.</p><p dir="RTL"><strong>قبل دهن الصبغة مرة أخرى</strong>، ينبغي <strong>تنظيف</strong> الظفر المصاب بماسحة طبية مشبعة بالأسيتون (يُستخدم لإازلة طلاء الأظافر أحيانًاً). إذا لم تفعل هذا، فسوف تزيد كثافة طبقة الصبغة المدهونة وتعوق وصول المادة الدوائية في صبغة دكتارين إلى الظفر المصاب.</p><p dir="RTL">ينبغي الاستمارر في استخدام العلاج حتى يبدأ ظفر جديد في النمو .لا تتوقف عن استخدام صبغة دكتارين إلا إذا أريت الظفر الجديد طبيعيا تمامًاً. سيستغرق هذا 3 أشهر على الأقل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--><!--[if gte vml 1]><v:group id="Group_x0020_13474" o:spid="_x0000_s1031"
 style='width:27.8pt;height:27.25pt;mso-position-horizontal-relative:char;
 mso-position-vertical-relative:line' coordsize="352964,345794" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF
dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ
gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI
+gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb
mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu
ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y
ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx
jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5
8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj
MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEABILjRDILAACTOwAA
HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWzsW1lvI8cRfg+Q/0Dw3Vbfh2CtgTjJ
vgTOYmX/gFmKOpDhkCC5svbf56s+ZkZcqVqK7TjIrh40lKamprqOr45ufvf9w6Zf3K/3h7vtcLGU
34rlYj2stld3w83F8uef/v5NWC4Ox2646vrtsL5Yfloflt+/+fOfvuvOb/bd7vZutQCH4XDeXSxv
j8fd+dnZYXW73nSHb7e79YB719v9pjviz/3N2dW++wWcN/2ZEsKdbbq7YflmYvXX7tgtPu7v/gNW
/Xb1r/XVD91w3x3Asl+dz/9TZOxXv55zdz7cv93vLnfv9iT56sf7d/vF3dXFEpobug1UtDwrNwoZ
/jw7eepmYvBwvd8Q/fb6evGQuHyi34nH+uG4WOGf2iqj7HKxwi1trDHl/ur2n088tbr9G/schMkv
xYeZIOkjSfLM+qQ23tQ1vt1vP+4W+V//S8uNDiIWNfloSI3PLPewy2v93JBY1WjLy9tut6Z1Vo3/
eE8PVJPWhw/FG06MKYVR3i8XMJv0Xvrw2KzeuyysdFGne6OscKyPh+Pb9Tb5Rnf/j8Mxqfnmqn7q
buun1cNQP+7Xq+OiT150TL/36feH0aN23ZGeo6XTx8UvF8skxS0kTELQnc32fv3TNtEcyScTRfVK
iDjd74en6ObLqRT1ukscrQSskFZsVHXhlaJeMyUsQXQ6CluMWe/X65xO+6hZstOlVCarfntYZ6uS
XpLXjLrCkufW6AdSGwRbdbuL5XXfHROGbe6O6/2iv9tAXOWFSB6DR/shcasucny4TJ53fPjL9uoT
KfkDrsmlQHs4Xh4/9SQJDES/1sPVu27fvQfI9B1h8nr45ufLskZQ4AUTp4+H9eXuPXwgr6S+6kAs
iVk/vF9fA6wSztA/DvubDz/0+8V9R06TftJaun5325X/lncV0vTGxIeev77r+5GlTI8+xTKLU4jT
qq6vIeX4pMhProo02WmxVui4ui7Wua4PpTdvh+n5AampipnXCvIc4GyYywpnY5hLYpNQ/RVhnn30
BLOlsMLqZ8HosUv9rgFeJUGMI3kQKtISpyCeB1B12ulujZBMVXnN0KAS1OtnhFJKE1WxT6Wq10pt
fESCo1CX0gvPUkdnFUxHxEoG2SAWGhQZRHS0vBzBK4kEQpyNF5GHpuAcKBKxBaDxYsyInVYA/hwT
VQ31mtURvNdwHRLDi+CqUSpRvRbiGIA1mThEyxNHpQOSDnEG3wb2RieAuok4KgH7cDJLIaRRhdo7
y69w5kdKSNmQ+hE1MsaLJYF7hJhiOgFxTlaP1RdN9Fl9StMS2EXG0ZmUjk7xug5OhqwQZYKSvEKC
si6bnD40kh1i2OUAUE7rwMvsXaA6AyZXLhrLa8MbFWIm9nBq3qe9wk8mDlLk6uZZPXshbQ4tBcVo
XmYH5yzaiMI17O28QFinBSK+Ne8czsRiFFhbRd6CTkWZA0ALE3IN+OwCnQgmw4EGcjSwwwYfstdp
qMXyQDNz/1dSZ7jnwrYI8VLCU319rZu+xLoJ0ZZb3bFuSmn1tXXTzK+lCijxCXtR55Xu1QVlSoOk
pDcjJtYma16T/64FVBEE9VOR46n6yWjgbEKhGiPP1VBWRdRgKa22EBYpGkhJpEE08hiKkYKv0rvI
A3dZEKUEpDy+Y5poNaqjuraaQ+s1lyKTDNoZADgHPEhcOqclLegTR2ujLzistEeHz9I6gdUn7Tb1
YGUseVQqZ/jMaEIaC0BnEaUOK4IxXuXs5W0jOcPpq4Ft5JUAfZX8IiUqBFYC5aWpLuY8nxFR8dqc
5Mi7eSVIh+SdlKtCkJGVgaTMWmg7Q6DCi2xmTGz4rkUNk0itto1mfyR11jdKXW+gfRLAOw3Q4Rxs
WlewsVFOyaCpBySnwdiuYQfnVHFcoaTilQuVomZOXi5gCD7cDRgXb8BkwvDE1ktdmitpfeD9YQp4
aMU3mrwJSUAMk7BanogfYX/Fm3rNuFPq93mSqAT1OidEr4aikn092j8Ukkm/LyAeowIFP422WPfB
qC9X2BDXNMysDCaIWQxndIOzikoWy1ktx+Fn1UC9Zk1oo2HbtEAjreNdfkIp+IaBR3MLhJy+cKZm
k/fjuWtGCM1zRnVfGm70dY1WzShXYA0DhSD4vl+HcSLZdvo5EDfDCa0++vccqGiied+YoBiT41aE
SAtfS5wjGnV+fchYpeuJACQeh4JFciGB0fu0aoPosyujy24kOovGMnENQC7e2wzGNJlUx1Z8hJLm
gIFjfVgdvV6zwyutMsIHQQHIeTBmSlkDPqDk4UkVchApywfteETLLIPAjIZlWV4Nx+FzvEdeT2/W
WvJCjpTo0fnYVTbbk0YGPPKPlM5rXpt5PZSCebNnOoPGmA+S0ToaZTS/8LEAgJUUXzZOWV0J1aId
szrBIb8qZUWZvrRrQQVuyaTaNuqwGV6JhvE/70tqXHzt3b/E3h1wddK7J0j4Fb17gqkn2/ZHk/8/
sG0vcjzVtmfUqUj7XMs+VaOVsgZRveYkM9GFqBvgNOvtMc/lcRnVKEoHQntkWpQ1XPaaKrsoMbRk
aaeCA3sq4xZ0XVO95rVNNYTEFByVJidEVusj+1du9Zq5PtZ/vfcVmr5EaELyO4Gm5L2vhiavMWFL
0XIKTehX0WI/cz7kv7gl67Igv8WObGEFaGhAU34l6FAJN8pqgpuswDats+hRk7JxbXSoM1pFYxwO
QWjml8chmJxgfMHSKmwfJxmw595aG+a0GUox6Wi0TQSlubx3prULpSyqzSQDtsWwo8jJi4a0NLIo
dhtpAiUmQDxBv9aNgRfwtugsmAgLsjIotHeZL6pNvojFxi5a8yQDDuzwyD+tLXioj5UBhTam2okv
djR5ndFIMzc8UcZGi6DHSpo2PPm2THuD/UWSAfvojdQKNehxRCeAMZyCpykwNfON+eMUcdhIdY3e
yyLQyoRFCoz9WTFwdLDEhpQIfL7OsFbQATooA3vyvrErj6lRmcrD63wrRDG3r7MbdPW8rW3AgLCI
gRED75wTAML7W9E0EZejMJwFc23yYkKFkWxjuDoFs0Jf5njLKSdHFG4eNtAuYqRJlsOOkUAbzy0M
u73Yck7E2Pdo7A9MDoTTFHR6hONsRzMrgGvDNZ3wBYKo5xY8ZwdgyXGK0abDuQNOjDmxdo0O2eHg
Rxmyto+5zDkL0ZgOTQvEaRvbOPNggyvJBsNN20CiWexh8IUA57SBnQfaSKWobi9wMrfEQLZhFBym
wNA/cwYm8WhvPKbjhdi2Njhm6BlxIIaPlBkuY0OvMY+irZOCni8gBhrnCkBir6dRWkwlAPTsBJ8n
caCKjhmTUdDStbYjkD9K4mkf28KhuLpA7KA3UiWmvUUZHrNUvsxCsi66QGZvZD9M6SpfoRsD36IG
5yXmrpwjF0I6isPnsUlSjB1bhdC4TylRGTacR0aaMyer+eZhOxVRRxcTN8Of9itKkAaceeLxbRZK
AVUL72mziG47j522zwO6KD7uLEqxXBcCnFveAxguGUp6TOB5V5tOB8AoWvPacBiHFsdsn63EPhr2
pJIFbVCNYhZhVwpfjFJkY/dmBuB4RePQGh09KMipsCPD5z7aUivEKMWxq84FyVT8ou6UjUQ5+TP2
kBoJCj1Qrg0jyhze5bLXt2dgme406L9Of77E6Q9g9WT6k8DntdMfHMzFfmgK8ORX02BaIn8TAv3x
458qyW8x/6m8UEicxlGdppb5bVk+CF/c0ryY8AWtFx3XySiN6QfaaBbD0M1kG7ZpqWfNfNszbJTV
5djta2jbQ7CMYy+lO7XTV7z7v8Q7nBQv36k8O/k6avoSVfn6LH3ndf73m38DAAD//wMAUEsDBBQA
BgAIAAAAIQCSfYfgHQcAAEkgAAAaAAAAY2xpcGJvYXJkL3RoZW1lL3RoZW1lMS54bWzsWUtvGzcQ
vhfof1jsvbFkvWIjcmDJctzEL0RKihwpidplzF0uSMqObkVy6qVAgbTooQF666EoGqABGvTSH2PA
QZv+iA65L1Ki4gdcIChsAcbu7DfD4czszOzwzt1nEfWOMReExW2/eqviezgesTGJg7b/aLD92W3f
ExLFY0RZjNv+DAv/7sann9xB6yNKkiFDfDwIcYQ9EBSLddT2QymT9ZUVMQIyErdYgmN4NmE8QhJu
ebAy5ugEFojoymql0lyJEIn9DZAolaAehX+xFIoworyvxGAvRhGsfjCZkBHW2PFRVSHETHQp944R
bfsgc8xOBviZ9D2KhIQHbb+i//yVjTsraD1jonIJr8G3rf8yvoxhfLSq1+TBsFi0Xm/Um5uFfA2g
chHXa/WavWYhTwPQaAQ7TXWxZbZWu/UMa4DSS4fsrdZWrWrhDfm1BZ03G+pn4TUolV9fwG9vd8GK
Fl6DUnxjAd/orHW2bPkalOKbC/hWZXOr3rLka1BISXy0gK40mrVuvtsCMmF0xwlfa9S3W6uZ8BIF
0VBEl1piwmK5LNYi9JTxbQAoIEWSxJ6cJXiCRhCTXUTJkBNvlwQhBF6CYiaAXFmtbFdq8F/96vpK
exStY2RwK71AE7FAUvp4YsRJItv+fZDqG5Czt29Pn785ff776YsXp89/zdbWoiy+HRQHJt/7n775
59WX3t+//fj+5bfp0vN4YeLf/fLVuz/+/JB42HFpirPvXr978/rs+6//+vmlQ/omR0MTPiARFt4+
PvEesgg26NAfD/nlOAYhIibHZhwIFCO1ikN+T4YWen+GKHLgOti242MOqcYFvDd9aincD/lUEofE
B2FkAfcYox3GnVZ4oNYyzDyYxoF7cT41cQ8ROnat3UWx5eXeNIEcS1wiuyG21DykKJYowDGWnnrG
jjB27O4JIZZd98iIM8Em0ntCvA4iTpMMyNCKppJph0Tgl5lLQfC3ZZu9x16HUdeut/CxjYR3A1GH
8gNMLTPeQ1OJIpfIAYqoafBdJEOXkv0ZH5m4npDg6QBT5vXGWAgXzwGH/RpOfwBpxu32PTqLbCSX
5MglcxcxZiK32FE3RFHiwvZJHJrYz8URhCjyDpl0wfeY/Yaoe/ADipe6+zHBlrvPzwaPIMOaKpUB
op5MucOX9zCz4rc/oxOEXalmk0dWit3kxBkdnWlghfYuxhSdoDHG3qPPHRp0WGLZvFT6fghZZQe7
Aus+smNV3cdYYE83N4t5cpcIK2T7OGBL9NmbzSWeGYojxJdJ3gevmzbvQamLXAFwQEdHJnCfQL8H
8eI0yoEAGUZwL5V6GCKrgKl74Y7XGbf8d5F3DN7Lp5YaF3gvgQdfmgcSu8nzQdsMELUWKANmgKDL
cKVbYLHcX7Ko4qrZpk6+if3Slm6A7shqeiISn9sBzfU+jf+u94EO4+yHV46X7Xr6HbdgK1ldstNZ
lkx25vqbZbj5rqbL+Jh8/E3NFprGhxjqyGLGuulpbnoa/3/f0yx7n286mWX9xk0n40OHcdPJZMOV
6+lkyuYF+ho18EgHPXrsEy2d+kwIpX05o3hX6MGPgO+Z8TYQFZ+ebuJiCpiEcKnKHCxg4QKONI/H
mfyCyLAfogSmQ1VfCQlEJjoQXsIEDI002Slb4ek02mPjdNhZrarBZlpZBZIlvdIo6DCokim62SoH
eIV4rW2gB625Aor3MkoYi9lK1BxKtHKiMpIe64LRHEronV2LFmsOLW4r8bmrFrQA1QqvwAe3B5/p
bb9RBxZggnkcNOdj5afU1bl3tTOv09PLjGlFADTYeQSUnl5Tui7dntpdGmoX8LSlhBFuthLaMrrB
EyF8BmfRqagXUeOyvl4rXWqpp0yh14PQKtVo3f6QFlf1NfDN5wYam5mCxt5J22/WGhAyI5S0/QkM
jeEySiB2hPrmQjSA45aR5OkLf5XMknAht5AIU4PrpJNmg4hIzD1Koravtl+4gcY6h2jdqquQED5a
5dYgrXxsyoHTbSfjyQSPpOl2g6Isnd5Chk9zhfOpZr86WHGyKbi7H45PvCGd8ocIQqzRqioDjomA
s4Nqas0xgcOwIpGV8TdXmLK0a55G6RhK6YgmIcoqipnMU7hO5YU6+q6wgXGX7RkMapgkK4TDQBVY
06hWNS2qRqrD0qp7PpOynJE0y5ppZRVVNd1ZzFohLwNztrxakTe0yk0MOc2s8Gnqnk+5a3mum+sT
iioBBi/s56i6FygIhmrlYpZqSuPFNKxydka1a0e+wXNUu0iRMLJ+Mxc7Z7eiRjiXA+KVKj/wzUct
kCZ5X6kt7TrY3kOJNwyqbR8Ol2E4+Ayu4HjaB9qqoq0qGlzBmTOUi/SguO1nFzkFnqeUAlPLKbUc
U88p9ZzSyCmNnNLMKU3f0yeqcIqvDlN9Lz8whRqWHbBmvYV9+r/xLwAAAP//AwBQSwMEFAAGAAgA
AAAhAJxmRkG7AAAAJAEAACoAAABjbGlwYm9hcmQvZHJhd2luZ3MvX3JlbHMvZHJhd2luZzEueG1s
LnJlbHOEj80KwjAQhO+C7xD2btJ6EJEmvYjQq9QHCMk2LTY/JFHs2xvoRUHwsjCz7DezTfuyM3li
TJN3HGpaAUGnvJ6c4XDrL7sjkJSl03L2DjksmKAV201zxVnmcpTGKSRSKC5xGHMOJ8aSGtHKRH1A
VzaDj1bmIqNhQaq7NMj2VXVg8ZMB4otJOs0hdroG0i+hJP9n+2GYFJ69elh0+UcEy6UXFqCMBjMH
SldnnTUtXYGJhn39Jt4AAAD//wMAUEsBAi0AFAAGAAgAAAAhALvlSJQFAQAAHgIAABMAAAAAAAAA
AAAAAAAAAAAAAFtDb250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEArTA/8cEAAAAyAQAA
CwAAAAAAAAAAAAAAAAA2AQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEABILjRDILAACTOwAA
HwAAAAAAAAAAAAAAAAAgAgAAY2xpcGJvYXJkL2RyYXdpbmdzL2RyYXdpbmcxLnhtbFBLAQItABQA
BgAIAAAAIQCSfYfgHQcAAEkgAAAaAAAAAAAAAAAAAAAAAI8NAABjbGlwYm9hcmQvdGhlbWUvdGhl
bWUxLnhtbFBLAQItABQABgAIAAAAIQCcZkZBuwAAACQBAAAqAAAAAAAAAAAAAAAAAOQUAABjbGlw
Ym9hcmQvZHJhd2luZ3MvX3JlbHMvZHJhd2luZzEueG1sLnJlbHNQSwUGAAAAAAUABQBnAQAA5xUA
AAAA
">
 <v:shape id="Shape_x0020_1340" o:spid="_x0000_s1032" style='position:absolute;
  left:104277;top:177178;width:776;height:16938;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' coordsize="776,16938" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m776,r,16938l518,15928,,13905,,3793,776,xe" fillcolor="black"
  stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,776,16938"/>
 </v:shape><v:shape id="Shape_x0020_1341" o:spid="_x0000_s1033" style='position:absolute;
  width:105053;height:345794;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="105053,345794" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m,l105053,r,111492l104795,111707r-8274,10110l90317,133952r-3103,13146l86698,155187r,8089l87733,170860r2067,8090l92386,186028r3619,6067l100142,197656r4911,3494l105053,209285r-4911,9606l94970,230014r-4653,9606l86182,248216r-3619,8089l79461,263384r-2585,6067l74289,275517r-2067,5561l70154,286134r-1551,4551l67052,295235r-2070,5055l62915,304840r-2067,5058l58780,315458r46273,l105053,345794,,345794,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,105053,345794"/>
 </v:shape><v:shape id="Shape_x0020_1342" o:spid="_x0000_s1034" style='position:absolute;
  left:105053;top:128390;width:68246;height:217405;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' coordsize="68246,217405" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m43687,r9307,1517l60234,8091r6720,9606l68246,20013r,18707l66954,36403,63336,30336,59715,23764,56097,17697,51961,12641,48340,9100,44723,7584,39034,8596r-5686,3034l27144,15675r-5689,6066l16286,28819r-4653,7584l8014,44997,5945,53593r,12135l7496,76346r4137,9605l18353,94545r8274,7584l36450,108197r9824,4550l57131,115781r9823,1011l68246,116657r,100748l,217405,,187068r14735,l16286,182518r3103,-8089l24042,164318r5169,-11124l34381,141566r4653,-10113l43171,123869r3103,-4550l45238,118814r-2583,-1012l38518,115781r-5170,-3034l27660,109208r-6205,-4551l15251,99602,10082,93535,8530,91513,6979,88984,5428,86456,4395,83929,2844,81905,2326,80389,1810,78872r-517,-505l,80895,,72760r775,552l775,70783,259,68761r,-2022l,65726,,48788,1810,39942,5945,29324r5688,-9100l18353,13146,25076,7584,32314,3541,38518,1012,43687,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,68246,217405"/>
 </v:shape><v:shape id="Shape_x0020_1343" o:spid="_x0000_s1035" style='position:absolute;
  left:105053;width:68246;height:111492;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="68246,111492" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m,l68246,r,89342l60234,87943,47308,88955,34381,91484,21455,96538r-11373,6573l,111492,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,68246,111492"/>
 </v:shape><v:shape id="Shape_x0020_1344" o:spid="_x0000_s1036" style='position:absolute;
  left:173299;width:66697;height:345794;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="66697,345794" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" path="m,l66697,r,23229l47309,23229,65404,40418r,2527l59717,45474r-7238,5055l43688,57102r-9305,7583l25594,72270r-7756,6572l13184,83393r-2067,1516l12151,85416r2068,505l17838,87438r4653,2022l27145,91988r5169,2529l37485,98055r4652,4044l44723,104628r2586,3033l50411,110695r2068,2528l55064,115750r1551,2024l57648,119290r518,506l66697,111842r,233952l,345794,,245047r13184,-1382l26109,239620r10859,-5561l45758,226475r6721,-8089l57648,210295r3103,-8089l61785,194622r,-1010l62302,192095r-517,-2023l60751,186534r-2068,2021l56615,190579r-2069,1516l52479,193106r-2587,1012l47825,195129r-3102,506l42137,196139r-5686,l30763,195129r-5169,-2528l20940,189568r-4653,-3540l12151,182488,8531,178444,4913,174399,1811,170356,,167110,,148403r4913,8806l11633,168839r8272,10111l29730,186534r12926,2528l47825,188051r4654,-2023l56097,182995r3102,-4551l61268,173894r2068,-5562l63853,163276r516,-5055l62819,148108,58683,136985,51962,125356,43172,114233,32314,104122,19905,96034,6464,90471,,89342,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,66697,345794"/>
 </v:shape><v:shape id="Shape_x0020_1345" o:spid="_x0000_s1037" style='position:absolute;
  left:239996;width:112968;height:345794;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="112968,345794" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l112968,r,345794l,345794,,111842,35933,78337r1033,l55063,96538r517,l55580,23229,,23229,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,112968,345794"/>
 </v:shape><w:wrap type="none"/>
 <w:anchorlock/>
</v:group><![endif]--><img width="38" height="37" src="file:///C:/Users/falmajmo/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.gif" /><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1026" type="#_x0000_t75" style='width:27.8pt;
 height:27.25pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]-->&nbsp;<strong>الآثار غير المرغوب فيها</strong></p><p dir="RTL">عادةً يكون ُّ تحمل المرضى لصبغة دكتارين جيدًاً.</p><p dir="RTL">وفي حالات نادةر؛ قد يحدث احمارر و/أو تهيج و/أو شعور بحرقة بسيطة أو حكة في موضع استخدام صبغة دكتارين .</p><p dir="RTL">في هذه الحالات؛ عادةً يكفي ترك مةر أو عدة مارت من استخدام الدواء.</p><p dir="RTL">فرط الحساسية تجاه دكتارين حالة نادةر جدًا. يمكن التعرف على هذه الحالة بأعارض مثل الحكة والاحمارر وضيق التنفس و/أو تورم الوجه بعد استخدام الدواء. في هذه الحالة يجب التوقف عن استخدام العلاج واستشاةر الطبيب أو الصيدلي.</p><p dir="RTL">وينبغي عدم التردد في إبلاغ الطبيب أو الصيدلي عن أية آثار مزعجة أخرى.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--><!--[if gte vml 1]><v:group id="Group_x0020_13475" o:spid="_x0000_s1026"
 style='width:28pt;height:27.9pt;mso-position-horizontal-relative:char;
 mso-position-vertical-relative:line' coordsize="355645,354236" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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">
 <v:shape id="Shape_x0020_1352" o:spid="_x0000_s1027" style='position:absolute;
  left:147310;top:262949;width:29649;height:60238;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' coordsize="29649,60238" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m3149,l29387,26713r262,l29649,33522r-262,l3149,60238,2624,59189,2099,58143,1049,57094,526,56046,26238,30381r,-524l,3143,3149,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,29649,60238"/>
 </v:shape><v:shape id="Shape_x0020_1353" o:spid="_x0000_s1028" style='position:absolute;
  width:176959;height:354236;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="176959,354236" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l176959,r,11502l8244,343092r88163,l96407,317425r-44080,l52327,316901,176959,67575r,105280l173548,172855r-6821,524l160953,175475r-4722,2619l152559,180713r-3150,3665l147836,186997r-1051,2619l146260,191712r1050,4191l148884,199045r2624,2619l154132,203759r22827,l176959,213189r-16529,l158855,228379r-3149,8903l150459,241472r-5247,2097l139438,244616r-5247,2095l131042,251949r-1574,10476l129468,339424r1574,1573l132617,341519r1574,1048l176959,342567r,11669l,354236,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,176959,354236"/>
 </v:shape><v:shape id="Shape_x0020_1354" o:spid="_x0000_s1029" style='position:absolute;
  left:176959;top:262949;width:29650;height:58665;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' coordsize="29650,58665" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m27026,r525,524l28601,1571r524,524l29650,3143,3935,29857r,524l29650,56046r,2619l26501,58665,788,33522r-788,l,26713r788,l27026,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,29650,58665"/>
 </v:shape><v:shape id="Shape_x0020_1355" o:spid="_x0000_s1030" style='position:absolute;
  left:176959;width:178686;height:354236;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="178686,354236" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l178686,r,354236l,354236,,342567r45393,l46442,340997r1050,-2095l48017,337329r526,-1570l48543,265569r-1575,-9428l43294,249854r-5247,-4190l32274,242521r-5773,-3143l21255,236234r-3675,-4714l16530,224187r,-10998l,213189r,-9430l24927,203759r2099,-1571l29650,199568r2098,-3665l32799,191712r-1051,-4190l29650,183854r-3149,-3141l22303,177569r-4723,-2094l12857,173902r-3674,-523l5511,172855r-5511,l,67575,788,65998,126734,317425r-45656,l81078,343092r88686,524l788,9952,,11502,,xe"
  fillcolor="black" stroked="f" strokeweight="0">
  <v:stroke miterlimit="83231f" joinstyle="miter"/>
  <v:path arrowok="t" textboxrect="0,0,178686,354236"/>
 </v:shape><w:wrap type="none"/>
 <w:anchorlock/>
</v:group><![endif]--><img width="38" height="38" src="file:///C:/Users/falmajmo/AppData/Local/Temp/1/msohtmlclip1/01/clip_image002.gif" /><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:28pt;
 height:27.9pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]-->&nbsp;<strong>الجرعة الازئدة</strong></p><p dir="RTL">في حالة استخدام صبغة دكتارين بقدر أكبر من الجرعة الموصوفة من الطبيب؛ قد يحدث بعض الاحمارر أو التورم أو الإحساس بحرقة. في هذه الحالة؛ يكفي ترك مةر أو مرتين من الاستخدام ثم الرجوع إلى جدول الجرعات العادي.</p><p dir="RTL">في حالة تناول صبغة دكتارين عن طريق الفم بدون قصد؛ قد يحدث تهيج للمعدة. يجب الاتصال بالطبيب للتأكد من عدم وجود أية مشكلات.</p><p>&nbsp;</p><p dir="RTL"><strong>معلومات للطبيب في حالة تناول جرعة ازئدة </strong></p><p dir="RTL">لا يتوفر ترياق محدد. هذا العلاج من النوع المصحوب بأعارض كما أنه علاج داعم. ولكن يجب الانتباه إلى مقدار</p><p dir="RTL">الكحول المَبَتَلَعة خصوصا في الأطفال. إذا كان المريض يستخدم أدوية أخرى (مثل وارفارين وخافضات سكر الدم الفموية وفينيتوين)؛ فقد تزيد التأثيارت الدوائية والتأثيارت الجانبية لهذه الأدوية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;<strong>كيفية تخزين دكتارين</strong></p><p dir="RTL">احرص دائمًا على حفظ الزجاجة مغلقة بطريقة صحيحة. يمكن الاحتفاظ بهذا الدواء لمدة محدودة فقط. لا تستخدم صبغة دكتارين بعد التاريخ المطبوع (الشهر والسنة) بعد علامة&quot; EXP&quot;، حتى لو كانت محفوظة بشكل سليم.</p><p>يُنصح بإعادة الأدوية القديمة إلى الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تستخدم صبغة دكتارين لعلاج <strong>عدوى الأظافر بالفطريات بما فيها الخمائر.</strong></p><p dir="RTL">المادة الفعالة في صبغة دكتارين هي <strong>ميكونازول</strong>.</p><p>&nbsp;</p><p dir="RTL">تتوفر صبغة دكتارين في زجاجات حجم 30 مل مع فرشاة مثبتة بغطاء الزجاجة، ويحتوي كل مليلتر من الصبغة على 20 مليجارمًاً من مادة ميكونازول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تحتوي الصبغة على مكونات أخرى، هي: بوليمارت أكريليك/أكريليت مشتركة، كحول، بروبيلين جليكول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة صاحبة التسجيل/الشركة المصنعة:</p><p dir="RTL">يتم استيفاء هذه البيانات بواسطة الشركة المشغلة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم آخر تحديث لنشةر المريض المرفقة في عبوة الدواء بتاريخ: 02 يناير 2014 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DAKTARIN
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DAKTARIN Cream:  White homogeneous cream. Each gram contains 20 mg of the active substance miconazole nitrate. 
DAKTARIN Powder:  White powder. Each gram contains 20 mg of the active substance miconazole nitrate. 
DAKTARIN Lotion:  White homogeneous emulsion. Each gram contains 20 mg of the active substance miconazole nitrate. 
DAKTARIN Tincture:  Clear, colorless solution. Each milliliter contains 20 mg of the active substance miconazole. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DAKTARIN Cream:  White homogeneous cream. Each gram contains 20 mg of the active substance miconazole nitrate. 
DAKTARIN Powder:  White powder. Each gram contains 20 mg of the active substance miconazole nitrate. 
DAKTARIN Lotion:  White homogeneous emulsion. Each gram contains 20 mg of the active substance miconazole nitrate. 
DAKTARIN Tincture:  Clear, colorless solution. Each milliliter contains 20 mg of the active substance miconazole. 
For excipients, see List of Excipients. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>DAKTARIN<sup>&reg;</sup> Cream</p><p>Skin infections due to dermatophytes or yeasts, and other fungi such as: <em>Tinea capitis, corporis, manuum, barbae, cruris, pedis</em> (athlete&rsquo;s foot).</p><p>Since DAKTARIN<sup>&reg;</sup> has an antibacterial effect on gram-positive bacteria, it may be used in mycoses secondarily infected with such bacteria (e.g. in napkin dermatitis).</p><p>DAKTARIN<sup>&reg;</sup> Powder</p><p>Usually in combination with cream or lotion:</p><p>-&nbsp; napkin dermatitis.</p><p>-&nbsp; treatment of inguinal and/or interdigital infections caused by dermatophytes or yeasts. The powder can be used prophylactically in socks and shoes.</p><p>DAKTARIN<sup>&reg;</sup> Lotion</p><p>Skin and nail infections due to dermatophytes or yeasts, and other fungi such as: <em>tinea corporis, manuum, barbae, cruris, pedis</em> (athlete&rsquo;s foot).</p><p>Since DAKTARIN<sup>&reg;</sup> has an antibacterial effect on certain gram-positive bacteria, it may be used in mycoses secondarily infected with such bacteria (e.g. in napkin dermatitis). <strong><em>DAKTARIN<sup>&reg;</sup> Tincture </em></strong></p><p>Nail and nailbed infections caused by dermatophytes or yeasts.</p><p>Adjuvant topical medication for the treatment of onychomycosis.</p><p>Since DAKTARIN<sup>&reg;</sup> has an antibacterial effect on certain gram-positive bacteria, it may be used in mycoses secondarily infected with such bacteria.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dosage</p><p>DAKTARIN<sup>&reg;</sup> Cream</p><p>Apply some cream to the lesions twice daily.&nbsp;</p><p>If the powder is used with the cream, a once daily application of both formulations is recommended.</p><p>The duration of therapy varies from 2 to 6 weeks depending on the localization and the severity of the lesion.</p><p>Treatment should be continued at least one week after disappearance of all signs and symptoms. <em>DAKTARIN<sup>&reg;</sup> Powder </em></p><p>Apply some powder to the lesions twice daily.</p><p>If the powder is used with the cream or lotion, a once daily application of both formulations is recommended.</p><p>A once daily prophylactic use of the powder in shoes and socks is sufficient.</p><p>The duration of therapy varies from 2 to 6 weeks depending on the localization and the severity of the lesion.</p><p>Treatment should be continued at least one week after disappearance of all signs and symptoms.</p><p>DAKTARIN<sup>&reg;</sup> Lotion</p><p>Skin infections</p><p>Apply some lotion to the lesions once or twice daily.&nbsp;</p><p>If the powder is used with the lotion, a once daily application of both formulations is recommended.</p><p>The duration of therapy varies from 2 to 6 weeks depending on the localization and the severity of the lesion.</p><p>Treatment should be continued at least one week after disappearance of all signs and symptoms. Nail infections</p><p>A small amount of lotion should be applied to and rubbed into and under the infected nail and the surrounding area once or twice daily. The treatment should be continued without interruption until the growth of a new nail has set in and definite cure can be observed (rarely less than 3 months).</p><p>DAKTARIN<sup>&reg;</sup> Tincture</p><p>Twice daily, a thick layer of tincture should be applied with a brush to the infected nail and the surrounding area and allowed to dry to an occlusive film. The treatment should be continued without interruption, until a new nail has started to grow and definite cure can be observed (rarely less than 3 months).</p><p>Administration</p><p>DAKTARIN<sup>&reg;</sup> Cream DAKTARIN<sup>&reg;</sup> Powder DAKTARIN<sup>&reg;</sup> Lotion</p><p>For topical use. Rub the cream into the skin with your finger until it has fully penetrated the skin.</p><p>For topical use.</p><p>For topical application to the skin or nail.</p><p>Skin infections</p><p>Rub the lotion into the skin with your finger until it has fully penetrated the skin. Nail infections</p><p>The infected nails should be cut as short as possible. Rub the lotion into and under the infected nail and the surrounding area. The treated nail should be covered with an occlusive bandage.</p><p>DAKTARIN<sup>&reg;</sup> Tincture</p><p>For topical application to the nail. The infected nails should be cut as short as possible. Twice daily, a thick layer of the tincture should be applied with a brush to the infected nail and the surrounding area and allowed to dry to an occlusive film. It is recommended to clean the nail and the surrounding area with acetone before every new application of the tincture.<strong> </strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DAKTARIN® is contraindicated in individuals with a known hypersensitivity to miconazole, another ingredient of the formulation or other imidazole derivatives. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If a reaction suggesting sensitivity or irritation should occur, the treatment should be discontinued.</p><p>DAKTARIN<em><sup>&reg;</sup></em> must not come into contact with the eyes.</p><p>Because the tincture is an alcoholic solution, it cannot be applied to open lesions, into the eyes or on mucous membranes.</p><p>DAKTARIN<em><sup>&reg;</sup></em> Powder contains talc. Avoid inhalation of the powder to prevent irritation of airways. In particular, when treating infants and children, careful application should be used to prevent inhalation by the child.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Miconazole administered systemically is known to inhibit CYP3A4/2C9. Due to the limited systemic availability after topical application (see Pharmacokinetic Properties), clinically relevant interactions occur very rarely. In patients on oral anticoagulants, such as warfarin, caution should be exercised and the anticoagulant effect should be monitored. The effects and side effects of some other drugs (e.g., oral hypoglycemics and phenytoin), when co-administered with miconazole, can be increased and caution should be exercised</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>DAKTARIN<em><sup>&reg;</sup></em> applied topically is minimally absorbed into the systemic circulation (bioavailability &lt; 1%). Although there is no evidence that miconazole is embryotoxic or teratogenic in animals, potential hazards of prescribing DAKTARIN<em><sup>&reg;</sup></em> Cream, Powder, Lotion, or Tincture during pregnancy should always be weighed against the expected therapeutic benefits.</p><p>Breast-feeding</p><p>Topically applied miconazole is minimally absorbed into the systemic circulation, and it is not known whether miconazole is excreted in human breast milk. Caution should be exercised when using topically applied miconazole products during lactation (see Interactions)<em>. </em>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Throughout this section, adverse reactions are presented. Adverse reactions are adverse events that were considered to be reasonably associated with the use of<em> </em>miconazole nitrate/miconazole based on the comprehensive assessment of the available adverse event information. A causal relationship with miconazole nitrate/miconazole cannot be reliably established in individual cases. Further, because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.</p><p>Clinical trial data</p><p>Adverse reactions reported among 834 patients who received miconazole nitrate 2% cream and/or placebo cream base in 21 double-blind clinical trials are presented in Table 1 below. Included in the table are all adverse events considered to be related to study drug. A dash indicates that the adverse reaction was not reported by patients in the specified treatment group.</p><p><strong>Table 1: Adverse reactions reported by patients in either treatment group in 21 doubleblind clinical trials of miconazole nitrate 2% cream versus placebo. </strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:498px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class </strong></p><p>Adverse reaction</p></td><td style="vertical-align:top"><p>Miconazole</p><p>Nitrate 2% Cream</p><p>(n=426), %</p></td><td style="vertical-align:top"><p>Placebo</p><p>Cream Base</p><p>(n=408), %</p></td></tr><tr><td style="vertical-align:top"><p><em>Overall adverse reactions </em></p></td><td style="vertical-align:top"><p><em>1.9 </em></p></td><td style="vertical-align:top"><p><em>1.2 </em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders </strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Skin burning sensation</p><p>Skin inflammation</p><p>Skin hypopigmentation<strong> </strong></p><p><strong>General disorders and administration site conditions </strong></p><p>Application site irritation</p><p>Application site burning</p><p>Application site pruritus</p><p>Application site reaction NOS</p><p>Application site warmth</p></td><td style="vertical-align:top"><p>0.2</p><p>0.2</p><p>0.2</p><p>&nbsp;</p><p>&nbsp;</p><p>0.7</p><p>0.2</p><p>0.2</p><p>0.2</p><p>0.2</p></td><td style="vertical-align:top"><p>0.7</p><p>--</p><p>--</p><p>&nbsp;</p><p>&nbsp;</p><p>0.5</p><p>0.2</p><p>--</p><p>--</p><p>--</p></td></tr></tbody></table><p>Note: Individual patients may have reported more than a single event.</p><p>Postmarketing data</p><p>In addition to the adverse reactions reported during clinical studies and listed above, the following adverse reactions have been reported during postmarketing experience (Table 2). In this table, the frequencies are provided according to the following convention:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very common &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/10</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/100 and &lt; 1/10</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/1000 and &lt;1/100</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/10000 and &lt;1/1000</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;1/10000, including isolated reports.</p><p>In Table 2, adverse reactions are presented by frequency category based on spontaneous reporting rates.</p><p><strong>Table 2: Adverse Reactions Identified During Post-Marketing Experience with </strong></p><p><strong>DAKTARIN<sup>&reg;</sup> by Frequency Category Estimated from Spontaneous Reporting Rates </strong></p><p>Immune system disorders</p><p><em>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>anaphylactic reaction, hypersensitivity, angioneurotic edema</p><p>&nbsp;</p><p>Skin and subcutaneous tissue disorders</p><p><em>Very rare</em> urticaria, contact dermatitis, rash, erythema, pruritus, skin burning sensation</p><p>&nbsp;</p><p>General disorders and administration site conditions</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>application site reactions, including application site</p><p>irritation&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cream, Powder, Lotion</p><p>Symptoms and signs</p><p>Topical use: Excessive use can result in skin irritation, which usually disappears after discontinuation of therapy.</p><p>Treatment</p><p>Accidental ingestion: DAKTARIN<em><u><sup>&reg;</sup></u></em> Cream, Powder, and Lotion are intended for topical use, not for oral use. Should accidental oral ingestion of large quantities of these products occur, use appropriate supportive care.</p><p>Accidental inhalation of talc-containing powder: Massive accidental aspiration of DAKTARIN<em><u><sup>&reg;</sup></u></em> Powder may cause impaction blockage of airways.&nbsp; Respiratory arrest should be treated with intensive supportive therapy and oxygen. If respiration is compromised, endotracheal intubation, removal of impacted material, and assisted breathing should be considered.</p><p>Tincture</p><p>Symptoms and signs</p><p>Topical use: Excessive use can result in skin irritation, which usually disappears after discontinuation of the therapy.</p><p>Accidental ingestion: Stomach irritation may occur.</p><p>Treatment</p><p>Accidental ingestion: A specific antidote is not available. Treatment is symptomatic and supportive. However, the quantity of alcohol that has been ingested must be taken into account, especially in children.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antifungals for dermatological/topical use; imidazole derivative, ATC code: D01A C02. <strong><em>Mechanism of action </em></strong></p><p>Miconazole inhibits the biosynthesis of ergosterol in fungi and changes the composition of other lipid components in the membrane, resulting in fungal cell necrosis.</p><p>Pharmacodynamic effects</p><p>Usually, miconazole acts very rapidly on pruritus, which frequently accompanies dermatophyte and yeast infections. This symptomatic improvement is seen before the first signs of healing are observed.</p><p>Miconazole has also been proven to be effective in secondarily infected mycoses.</p><p>Microbiology</p><p>Miconazole combines an antifungal activity against the common dermatophytes, yeasts and various other fungi with an antibacterial activity against certain gram-positive bacilli and cocci.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Miconazole remains in the skin after topical application for up to 4 days. Systemic absorption of miconazole is limited, with a bioavailability of less than 1% following topical application of miconazole. Plasma concentrations of miconazole and/or its metabolites were measurable 24 and 48 hours after application.</p><p>Systemic absorption has also been demonstrated after repeated application of miconazole to infants with diaper dermatitis. Plasma levels of miconazole were undetectable or low in all infants.</p><p>Distribution Metabolism and Excretion</p><p>Absorbed miconazole is bound to plasma proteins (88.2%) and red blood cells (10.6%).</p><p>The small amount of miconazole that is absorbed is eliminated predominantly in feces as both unchanged drug and metabolites over a four-day post-administration period. Smaller amounts of unchanged drug and metabolites also appear in urine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of local irritation, single and repeated dose toxicity, genotoxicity, and toxicity to reproduction.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>DAKTARIN<sup>&reg;</sup> Cream: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; benzoic &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acid, &nbsp;&nbsp; butylated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hydroxyanisole, liquid &nbsp; paraffin, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; oleoyl macrogolglycerides, PEG-6 (and) PEG-32 (and) glycol stearate, purified water.</p><p>DAKTARIN<sup>&reg;</sup> Powder: colloidal silicon dioxide, talc, zinc oxide.</p><p>DAKTARIN<sup>&reg;</sup> Lotion: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; benzoic &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acid, &nbsp;&nbsp; butylated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hydroxyanisole, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; liquid &nbsp; paraffin, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; oleoyl macrogolglycerides, PEG-6 (and) PEG-32 (and) glycol stearate, purified water. DAKTARIN<sup>&reg;</sup> Tincture: acrylic/acrylate copolymer, alcohol. propylene glycol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                See expiry date on the outer pack. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>See storage condition on the outer pack.</p><p>Keep DAKTARIN<sup>&reg;</sup> out of reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>DAKTARIN<sup>&reg;</sup> Cream<em> </em>is supplied in tubes of 15 g and 30 g.</p><p>DAKTARIN<sup>&reg;</sup> Powder<em> </em>is supplied in shakers of 20 g.</p><p>DAKTARIN<sup>&reg;</sup> Lotion is supplied in sprays of 30 g, containing no propelling gas.</p><p>DAKTARIN<sup>&reg;</sup> Tincture (containing 20 mg of miconazole per ml) is supplied in 30 ml bottles (with brush).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>DAKTARIN<sup>&reg;</sup> Cream<strong><em>:</em></strong> To open the tube, unscrew the cap. Then pierce the seal of the tube with the pin on the top of the cap.</p><p>DAKTARIN<sup>&reg;</sup> Powder:<strong><em> </em></strong>Not applicable.</p><p>DAKTARIN<sup>&reg;</sup> Lotion:<em> </em>Shake the spray before use and press the pump a few times before spraying.</p><p>DAKTARIN<sup>&reg;</sup> Tincture:<strong><em> </em></strong>Use the brush attached to the cap of the bottle to apply the tincture.</p><p>Instructions for Disposal</p><p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                See outer carton. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 January 2014 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>